China builds plants for mRNA vaccines still in development limbo

CanSino, Sinopharm seek Chinese equivalents of Pfizer and Moderna shots

20221012N China vaccine

Sinovac Biotech is among the Chinese players that have developed convential vaccines against COVID-19. © Reuters

SHIN WATANABE, Nikkei staff writer

SHANGHAI -- Chinese drugmakers are building factories meant to produce mRNA vaccines like the Western ones that have been shown to work against COVID-19. There's one problem: the shots look increasingly likely not to be ready by the time the plants are completed.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.